Biolase Stock Analysis

BIOLASE Stock Analysis Notes

The company has price-to-book (P/B) ratio of 0.77. Some equities with similar Price to Book (P/B) outperform the market in the long run. BIOLASE recorded a loss per share of 29.44. The entity last dividend was issued on the 24th of June 2005. The firm had 1:100 split on the 28th of July 2023. BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. BIOLASE, Inc. was founded in 1984 and is headquartered in Foothill Ranch, California. Biolase operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 158 people. For more info on BIOLASE please contact Harold Flynn at 949 361 1200 or go to https://www.biolase.com.

BIOLASE Investment Alerts

BIOLASE Upcoming and Recent Events

BIOLASE Largest EPS Surprises

View All Earnings Estimates

BIOLASE Stock Institutional Investors

Note, although BIOLASE's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

BIOLASE Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.99 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BIOLASE's market, we take the total number of its shares issued and multiply it by BIOLASE's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

BIOLASE Profitablity

The company has Profit Margin (PM) of (0.42) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.35) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.35.

Management Efficiency

BIOLASE has return on total asset (ROA) of (0.2855) % which means that it has lost $0.2855 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (6.0283) %, meaning that it created substantial loss on money invested by shareholders. BIOLASE's management efficiency ratios could be used to measure how well BIOLASE manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is expected to rise to 87.71 this year, although the value of Return On Tangible Assets will most likely fall to (0.67). At this time, BIOLASE's Non Currrent Assets Other are quite stable compared to the past year. Other Current Assets is expected to rise to about 1.5 M this year, although the value of Non Current Assets Total will most likely fall to about 5.7 M.

Technical Drivers

As of the 23rd of April, BIOLASE shows the risk adjusted performance of (0.1), and Mean Deviation of 6.94. BIOLASE technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to break down and interpolate data for thirteen technical drivers for BIOLASE, which can be compared to its peers. Please confirm BIOLASE variance and potential upside to decide if BIOLASE is priced favorably, providing market reflects its regular price of 0.15 per share. As BIOLASE appears to be a penny stock we also recommend to validate its jensen alpha numbers.

BIOLASE Price Movement Analysis

BIOLASE Insider Trading Activities

BIOLASE Predictive Daily Indicators

BIOLASE Forecast Models

BIOLASE's time-series forecasting models are one of many BIOLASE's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary BIOLASE's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how BIOLASE prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling BIOLASE shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as BIOLASE. By using and applying BIOLASE Stock analysis, traders can create a robust methodology for identifying BIOLASE entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. BIOLASE analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. BIOLASE analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

BIOLASE stock analysis indicators help investors evaluate how BIOLASE stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading BIOLASE shares will generate the highest return on investment. By understating and applying BIOLASE stock analysis, traders can identify BIOLASE position entry and exit signals to maximize returns.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BIOLASE. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more information on how to buy BIOLASE Stock please use our How to buy in BIOLASE Stock guide.You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

When running BIOLASE's price analysis, check to measure BIOLASE's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BIOLASE is operating at the current time. Most of BIOLASE's value examination focuses on studying past and present price action to predict the probability of BIOLASE's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BIOLASE's price. Additionally, you may evaluate how the addition of BIOLASE to your portfolios can decrease your overall portfolio volatility.

Is BIOLASE's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BIOLASE. If investors know BIOLASE will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BIOLASE listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of BIOLASE is measured differently than its book value, which is the value of BIOLASE that is recorded on the company's balance sheet. Investors also form their own opinion of BIOLASE's value that differs from its market value or its book value, called intrinsic value, which is BIOLASE's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BIOLASE's market value can be influenced by many factors that don't directly affect BIOLASE's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between BIOLASE's value and its price as these two are different measures arrived at by different means. Investors typically determine if BIOLASE is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BIOLASE's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.